Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs.
Biogen has arrived at a highly unusual solution to a dispute surrounding a patent for its blockbuster multiple sclerosis drug Tecfidera. It has agreed to pay Denmark’s Forward Pharma $1.25 ...
Pre-Market: 5:58:06 a.m. EDT Loading Chart for BIIB ...
Partly cloudy. Slight chance of a shower early this evening. The chance of a thunderstorm early this evening. Light winds. Sun protection recommended from 9:40 am to 4:40 pm, UV Index predicted to ...
After hours: 13 March at 7:37:36 pm GMT-4 Loading Chart for BIIB ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Dividend announcements are not available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results